Pfizer's intent was on developing a new "wonder-drug" that would lower a person's "bad" cholesterol (or LDL) while simultaneously raising the "good" cholesterol (HDL).  What they got, however, were rising blood pressures, deaths, and heart problems. 

  Thank goodness Pfizer pulled the plug on their study, called Illuminate, that was schedule to be completed in 2009.
   
   If you are seeking more information on the cholesterol hype, here is my recent blog and Ron Rosedale M.D. on the topic.